[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2021314940A1 - Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester - Google Patents

Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester

Info

Publication number
AU2021314940A1
AU2021314940A1 AU2021314940A AU2021314940A AU2021314940A1 AU 2021314940 A1 AU2021314940 A1 AU 2021314940A1 AU 2021314940 A AU2021314940 A AU 2021314940A AU 2021314940 A AU2021314940 A AU 2021314940A AU 2021314940 A1 AU2021314940 A1 AU 2021314940A1
Authority
AU
Australia
Prior art keywords
dihydronaphthalen
piperdine
dioxo
methyl
ylmethyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2021314940A
Other versions
AU2021314940B2 (en
Inventor
Cheng Sun
Yuejun Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong University
Original Assignee
Nantong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202110095726.8A external-priority patent/CN112773800B/en
Application filed by Nantong University filed Critical Nantong University
Publication of AU2021314940A1 publication Critical patent/AU2021314940A1/en
Application granted granted Critical
Publication of AU2021314940B2 publication Critical patent/AU2021314940B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2021314940A 2021-01-25 2021-09-05 Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester Active AU2021314940B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110095726.8A CN112773800B (en) 2021-01-25 2021-01-25 Use of piperidine-1-dithiocarboxylate-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-2-methyl ester
CN202110095726.8 2021-01-25
PCT/CN2021/116577 WO2022022748A1 (en) 2021-01-25 2021-09-05 Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester

Publications (2)

Publication Number Publication Date
AU2021314940A1 true AU2021314940A1 (en) 2022-02-03
AU2021314940B2 AU2021314940B2 (en) 2022-05-19

Family

ID=75758904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021314940A Active AU2021314940B2 (en) 2021-01-25 2021-09-05 Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester

Country Status (3)

Country Link
CN (1) CN112773800B (en)
AU (1) AU2021314940B2 (en)
WO (1) WO2022022748A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112773800B (en) * 2021-01-25 2021-10-15 南通大学 Use of piperidine-1-dithiocarboxylate-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-2-methyl ester
CN114159437B (en) * 2021-10-29 2023-07-18 北京大学 Application of C3K and its pharmaceutically acceptable salt in preparation of medicine for treating hypertension

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281422A (en) * 1964-01-15 1966-10-25 Bayer Ag Sulfur-containing naphthoquinones
AU2007281911B2 (en) * 2006-08-04 2014-02-06 Beth Israel Deaconess Medical Center Inhibitors of pyruvate kinase and methods of treating disease
US20110218176A1 (en) * 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20120302609A1 (en) * 2011-05-25 2012-11-29 Dynamix Pharmaceuticals Ltd. Pyrazolines for the Modulation of PKM2
WO2014139144A1 (en) * 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
CN107226789B (en) * 2017-05-09 2019-11-08 北京大学 Carbamate compound, its preparation method and its use in the preparation of antitumor drugs
WO2019104142A2 (en) * 2017-11-21 2019-05-31 Georgia State University Research Foundation , Inc. System and methods to promote cellular regeneration following ischemia
CN108653736A (en) * 2018-04-28 2018-10-16 中国人民解放军第二军医大学 Application of the M2 types pyruvate kinase as drug target in the drug for preparing prevention psoriasis
CN112773800B (en) * 2021-01-25 2021-10-15 南通大学 Use of piperidine-1-dithiocarboxylate-3-methyl-1,4-dioxo-1,4-dihydronaphthalene-2-methyl ester

Similar Documents

Publication Publication Date Title
EP3982949A4 (en) Inhibitors of sarm1
EP3971190A4 (en) Heterocycle-fused pyrimidine derivative and use thereof
EP3907225A4 (en) Imidazopyridine derivative compounds and use of same
EP4028013A4 (en) Inhibitors of sarm1
AU2021314940A1 (en) Use of piperdine-1-carbodithioic acid-3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylmethyl ester
EP4028085A4 (en) Intranasal administration of esketamine
AU2021399009A9 (en) Isocycloseram formulation
EP4026548A4 (en) Use of 5-methyltetrahydrofolate
EP4119233A4 (en) Atomizer
EP4064827A4 (en) Methods of transformation
EP4017973A4 (en) Biosynthesis of eriodictyol
EP3801532A4 (en) Formulations of raltegravir
EP4055154A4 (en) Biosynthesis of para-nitro-l-phenylalanine
EP4119236A4 (en) Atomizer
EP4119235A4 (en) Atomizer
EP4119234A4 (en) Atomizer
EP4023219A4 (en) Nanoemulsion of 18beta-glycyrrhetinic acid
EP3906806A4 (en) Structure of case body
HK40110048A (en) Use of mazdutide
HK40106921A (en) Use of mazdutide
HK40091795A (en) Use of 5-nitro-8-hydroxyquinoline
HK40108760A (en) Therapeutic derivatives of interleukin-22
HK40079539A (en) Therapeutic derivatives of interleukin-22
HK40091921A (en) Enema formulation
HK40090302A (en) Solid forms of pralsetinib